
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is a leading medical technology firm with a diverse product portfolio and strong market share in imaging and ultrasound equipment globally. Despite inflationary pressures and supply chain disruptions affecting their margins in the short term, the company is well-positioned for long-term sustainable growth in the $110B healthcare market. Their track record of mitigating cost increases and ability to introduce new, higher-ASP products should drive future margins and shareholder value.
Bears say
GE HealthCare Techs is facing headwinds, including declining revenue in the patient care solutions segment due to concentrated monitoring installations and a decline in China's sales. While the company has strong market share in imaging and ultrasound equipment, the recent tariff and inflationary impacts on the P&L have hindered margin expansion. Furthermore, there is a risk of macroeconomic challenges and competition in the global market, as well as potential regulatory challenges in international markets, which could negatively affect future revenue growth.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares